Peptide Library

In clinical trials

Digestive & weight

CagriSema

Evidence

Clinical trials

Class

Combination of an amylin analog and a GLP-1 agonist

/

CagriSema

KEY TAKEAWAY

CagriSema combines cagrilintide, an amylin analog, with semaglutide, a GLP-1 receptor agonist, in one weekly injection. CagriSema is still being studied in clinical trials. Check the current regulatory status before relying on this entry.

Written by the Veylo editorial team · Updated

November 2026

At a glance

At a glance

What it is

Combination of an amylin analog and a GLP-1 agonist

Being studied for

Studied for obesity and type 2 diabetes

Key fact

CagriSema is still being studied in clinical trials. Check the current regulatory status before relying on this entry.

Route

Weekly subcutaneous injection in trials

Evidence strength

Clinical trials

What it is

What it is

CagriSema combines cagrilintide, an amylin analog, with semaglutide, a GLP-1 receptor agonist, in one weekly injection.

How it works

How it works

The two drugs act on different appetite pathways, so together they are meant to reduce weight more than either one alone.

Regulatory status

Regulatory status

CagriSema is still being studied in clinical trials. Check the current regulatory status before relying on this entry.

What it is used for

What it is used for

Studied for obesity and type 2 diabetes.

Side effects and risks

Side effects and risks

Nausea, vomiting and constipation were the most common effects in trials.

Citations

Citations

CagriSema: see PubMed and ClinicalTrials.gov for published studies and registered trials. No FDA drug label exists for the uses described.

Veylo content is educational and not medical advice. Peptides that are not FDA-approved are not approved for the uses described.

Veylo

Clinician-guided peptide care, paired with baseline blood testing and ongoing support.

Peptides referenced on this site are compounded medications and are investigational; they have not been approved by the FDA for the uses described. Nothing here is medical advice. Prescriptions are issued only after a licensed clinician reviews your history.

© 2026 Veylo. All rights reserved.

Veylo

Veylo

Veylo